You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Prostate cancer

Degarelix for treating advanced hormone-dependent prostate cancer

Technology appraisal guidance
Reference number: TA404
Published: 24 August 2016

Guidance
Tools and resources
Information for the public
Evidence
History

Response to scrutiny letter

Response to scrutiny letter

Response to scrutiny letter
25 June 2014
(398.22 Kb 55 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 25 June 2014